Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

International Business Machines Corp. (IBM) News: Partnership With Rosetta, Former CEO on Bloomberg Privacy, Power7+ Servers & More

Page 1 of 2

Related Tickers: International Business Machines Corp. (NYSE:IBM), JPMorgan Chase & Co. (NYSE:JPM), Goldman Sachs Group, Inc. (NYSE:GS)

Rosetta Builds on Commerce Momentum as Platinum Sponsor at IBM Smarter Commerce Global Summit (PR Newswire)
Rosetta, a leading customer engagement agency and independent brand in the Publicis Groupe, is building on its run of new Commerce assignments with the Platinum Sponsorship of the IBM Smarter Commerce Global Summit 2013, which begins Tuesday, May 21 and runs through Thursday, May 23 in Nashville, TN. Rosetta, Publicis and International Business Machines Corp. (NYSE:IBM) recently expanded a 10+ year global partnership that capitalized on the global reach of the Publicis Groupe network to establish Rosetta as the agency best positioned to capture a major portion of the global commerce market. The agency has completed more than 100 commerce implementations and expects commerce-related revenues to top $100 million this year.

International Business Machines Corp. (NYSE:IBM)Former IBM boss Palmisano to probe Bloomberg privacy breach (Information Age)
News and financial information agency Bloomberg has appointed Sam Palmisano, former CEO of International Business Machines Corp. (NYSE:IBM), to conduct an independent review of its privacy and data handling practices. The probe follows news that Bloomberg journalists accessed information about how certain clients, including JPMorgan Chase & Co. (NYSE:JPM) and Goldman Sachs Group, Inc. (NYSE:GS), used its paid-for financial data terminals while researching stories. The practice came to light after a Bloomberg journalist in Hong Kong asked Goldman Sachs why a certain executive had not logged into the terminal for a while. Co-founder and editor-in-chief Matt Winkler admitted that journalists have access to client log-in details as a way to find out what topics they were interested. “The error is inexcusable,” he wrote.

COBOL gets a web-friendly facelift on IBM mainframes (ZDNet)
International Business Machines Corp. (NYSE:IBM) has overhauled how the 50-year-old programming language COBOL runs on its System z mainframes to give COBOL apps a web-friendly facelift. Despite COBOL’s age IBM estimates that more than 200 billion lines of COBOL code are still being used across industries such as banking, insurance and retail. IBM is attempting to streamline development of COBOL apps for its System z mainframes with the latest release of IBM Enterprise COBOL for z/OS, its COBOL compiler for z/OS. COBOL apps using the compiler should see improved performance, with IBM claiming that in testing some applications’ performance increased by 10 to 20 percent.

DOST Strengthens R&D Capabilities with IBM Supercomputer (PC Advisor)
The Department of Science and Technology (DOST), the University of the Philippines (UP) and International Business Machines Corp. (NYSE:IBM) have announced that the world-renowned IBM Blue Gene supercomputer has been chosen to support the Philippine government’s priority R&D projects focused on reducing poverty, improving government processes and tools and enabling smarter weather management, as based on the National Economic Development Authority’s Medium Term Development Plan. A priority initiative around weather prediction will be the pilot project to use the IBM Blue Gene supercomputer as its platform.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!